Hospira Issues a Voluntary Nationwide Recall for Hydromorphone HCL Injection, USP CII Due to The Potential for Empty or Cracked Glass Vials


Hospira, Inc., a Pfizer firm, is voluntarily recalling three a lot of Hydromorphone HCl Injection, USP CII 10 mg/mL, 1 mL in 2 mL Single Dose Vials lot numbers 71330DD (NDC 0409-2634-01), and 691853F and 700753F (NDC 0703-0110-01 – Teva tons) to the hospital/establishment degree. Hospira, Inc. initiated this recall on February 07, 2018 because of the potential that models from these tons could also be empty or cracked on the backside of the glass vial.

Source link


Please enter your comment!
Please enter your name here